10,492 results match your criteria: "Journal of the American Society of Nephrology : JASN[Journal]"

Nanotherapeutics in Kidney Disease: Innovations, Challenges, and Future Directions.

J Am Soc Nephrol

December 2024

NanoTheranostics Laboratory, Australian Centre for Blood Diseases, School of Translational Medicine, Monash University, Melbourne, VIC, Australia.

The treatment and management of kidney disease present a significant global challenge, affecting over 800 million individuals and necessitating innovative therapeutic strategies that transcend symptomatic relief. The application of nanotechnology to renal therapies, while still in its early stages, holds transformative potential for improving treatment outcomes. Recent advancements in nanoparticle-based drug delivery leverage the unique physicochemical properties of nanoparticles for targeted and controlled therapeutic delivery to the kidneys.

View Article and Find Full Text PDF

Background: Hemodialysis (HD) contributes significantly to healthcare's carbon footprint. Worldwide about 100,000 dialysis machines end their life cycle each year. Our aim was to analyze the composition and the potential for recyclability of two dialysis machines, from the two companies with the largest market share, which had met their end-of-use terms (10-12 years of use according to French regulations).

View Article and Find Full Text PDF

Background: Structure and function in the mammalian kidney are organized along a radial axis highlighted by the corticomedullary organization and regional patterning of the collecting system. The arborised collecting epithelium arises through controlled growth, branching and commitment of Wnt11+ ureteric progenitor cells within cortically localized branch tips until postnatal day 3.

Methods: We applied in situ hybridization and immunofluorescence to key markers of collecting duct cell types to examine their distribution in the embryonic and postnatal mouse kidneys.

View Article and Find Full Text PDF

Macrophage-Derived Type I IFN, Renal Tubular Epithelial Cell Polyploidization, and AKI-to-CKD Transition.

J Am Soc Nephrol

December 2024

Department of Nephrology, Chongqing Key Laboratory of Prevention and Treatment of Kidney Disease, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing 400037, China.

Background: Acute kidney injury (AKI) is recognized as a common risk factor for chronic kidney disease (CKD). Renal tubular epithelial cell polyploidization after AKI is closely associated with maladaptive repair, while the regulatory and molecular mechanisms remain poorly understood. Here, we set out to investigate the mechanism of tubular epithelial cell polyploidization and their role in the AKI-to-CKD transition.

View Article and Find Full Text PDF

Tubular FoxP2 and Kidney Fibrosis.

J Am Soc Nephrol

December 2024

Division of Nephrology, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong.

Article Synopsis
  • The study investigates the role of the transcription factor Foxp2 in kidney fibrosis, a key process leading to chronic kidney disease (CKD) and kidney failure, highlighting its correlation with epithelial-to-mesenchymal transition (EMT).
  • Analysis of human kidney biopsies and experiments in genetically modified mice demonstrate that increased Foxp2 expression is associated with various forms of CKD, and its deletion reduces inflammation and fibrosis in kidney tissue.
  • Findings reveal that Foxp2 influences key cellular mechanisms, including the regulation of TGF-β signaling and cell cycle, ultimately affecting the progression of kidney fibrosis through the modulation of target genes related to cell growth and ECM production.
View Article and Find Full Text PDF

Authors' Reply: Using VNtyper from Whole Exome Sequencing Data to Detect Pathogenic Variants in the MUC1 Gene.

J Am Soc Nephrol

December 2024

Soins Intensifs Néphrologiques et Rein Aigu (SINRA), Nephrology Department, Tenon Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France.

View Article and Find Full Text PDF

Background: Nephrology is one of the pediatric subspecialties with the largest workforce shortage in the US. Waitlist registration is one of the first steps towards kidney transplantation and is facilitated by pediatric nephrologists. The objective of this study was to determine whether state-level density of pediatric nephrologists is associated with access to waitlisting (primary outcome) or kidney transplantation (secondary outcome) in children with kidney failure.

View Article and Find Full Text PDF
Article Synopsis
  • * A study reviewed 21 MLIV patients and conducted experiments on MLIV mouse models to understand kidney function, revealing that adult patients often have chronic kidney disease along with altered kidney functions and structure in the mice due to issues with endolysosomal function and autophagy.
  • * Results showed decreased kidney function, presence of fibrosis and inflammation in MLIV models, and impaired uptake of essential proteins, which highlights cellular and systemic dysfunction in the
View Article and Find Full Text PDF

Xenotransplantation: The Future Is Here.

J Am Soc Nephrol

November 2024

Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and Nephrology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article and Find Full Text PDF

Background: Our knowledge of X-linked Alport Syndrome comes mostly from selected cohorts with more severe disease.

Methods: We examined the phenotypic spectrum of X-linked Alport Syndrome in males and females with a genotype-based approach using data from the Geisinger MyCode DiscovEHR study, an unselected health system-based cohort with exome sequencing and electronic health records. Patients with COL4A5 variants reported as pathogenic or likely pathogenic in ClinVar, or protein-truncating variants, were each matched with up to 5 controls without COL4A3/4/5 variants by sociodemographics, diabetes diagnosis, and year of first outpatient encounter.

View Article and Find Full Text PDF

Need to Advance Pain Management in Kidney Failure beyond Opioid Medications.

J Am Soc Nephrol

December 2024

Department of Medicine, Hennepin Healthcare Research Institute, University of Minnesota, Minneapolis, Minnesota.

View Article and Find Full Text PDF

SPRINTing to Conclusions: Evaluating the Long-Term Effects of Intensive BP Control on Kidney Health.

J Am Soc Nephrol

December 2024

Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.

View Article and Find Full Text PDF

LAPTM5: A Novel Target in an Old Fight against Tubular Senescence.

J Am Soc Nephrol

December 2024

Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany; and Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Berlin, Germany.

View Article and Find Full Text PDF